Search Results - "DORVAL, T"

Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie by Mariani, P, Piperno-Neumann, S, Servois, V, Berry, M.G, Dorval, T, Plancher, C, Couturier, J, Levy-Gabriel, C, Lumbroso-Le Rouic, L, Desjardins, L, Salmon, R.J

“…Abstract Background Uveal melanoma is characterised by a high prevalence of liver metastases and a poor prognosis. Aim To review the evolving surgical…”
Get full text

Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience by Staudacher, L., Cottu, P.H., Diéras, V., Vincent-Salomon, A., Guilhaume, M.N., Escalup, L., Dorval, T., Beuzeboc, P., Mignot, L., Pierga, J.Y.

“…Although recent experimental data strongly suggest that platinum-based chemotherapy (PBCT) could improve the outcome of triple-negative breast cancer (TNBC),…”
Get full text

Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa by Comte, A., Jdid, W., Guilhaume, M. N., Kriegel, I., Piperno-Neumann, S., Dieras, V., Dorval, T., Pierga, J. Y., Cottu, P. H., Mignot, L., Bidard, F. C.

“…Treatment of breast cancer meningeal carcinomatosis (MC) relies on intrathecal chemotherapy. Thiotepa is one of the few drugs approved in this setting,…”
Get full text

Three-dimensional point spread function model for line-scanning confocal microscope with high-aperture objective by DUSCH, E, DORVAL, T, VINCENT, N, WACHSMUTH, M, GENOVESIO, A

“…Point Spread Function (PSF) modelling is an important task in image formation analysis. In confocal microscopy, the exact PSF is rarely known, thus one has to…”
Get full text

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer: the role of clinical response by Pierga, J.-Y, Mouret, E, Laurence, V, Diéras, V, Savigioni, A, Beuzeboc, P, Dorval, T, Palangié, T, Jouve, M, Pouillart, P

“…The aim of this retrospective study was to assess predictive factors for clinical response to preoperative chemotherapy and prognostic factors for survival…”
Get full text

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer by PIERGA, J-Y, MOURET, E, EXTRA, J-M, ASSELAIN, B, POUILLART, P, DIERAS, V, LAURENCE, V, BEUZEBOC, P, DORVAL, T, PALANGIE, T, JOUVE, M, VINCENT-SALOMON, A, SCHOLL, S

“…Neoadjuvant chemotherapy is able to reduce the size of the majority of breast tumours and down-stage axillary-node status. The aim of this study was to assess…”
Get full text

Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy by Leyvraz, S, Spataro, V, Bauer, J, Pampallona, S, Salmon, R, Dorval, T, Meuli, R, Gillet, M, Lejeune, F, Zografos, L

“…Ocular melanoma is characterized by a high rate of liver metastases and is associated with a median survival time less than 5 months. There is no standard…”
Get more information

Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients by Keilholz, U, Conradt, C, Legha, S S, Khayat, D, Scheibenbogen, C, Thatcher, N, Goey, S H, Gore, M, Dorval, T, Hancock, B, Punt, C J, Dummer, R, Avril, M F, Bröcker, E B, Benhammouda, A, Eggermont, A M, Pritsch, M

“…In patients with stage IV melanoma, durable responses have been reported with treatment regimens that involve high-dose interleukin-2 (IL-2). We analyze…”
Get more information

Microbiology and management of malignant breast cancer wounds in geriatric oncology by Rollot, F, Kriegel, I, Dorval, T, Baffie, A, Rivat, A, Fromantin, I

Get full text

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6 by Scholl, S M, Fourquet, A, Asselain, B, Pierga, J Y, Vilcoq, J R, Durand, J C, Dorval, T, Palangié, T, Jouve, M, Beuzeboc, P

“…The aim of this study was to assess a potential advantage in survival by neoadjuvant as compared to adjuvant chemotherapy. 414 premenopausal patients with…”
Get more information

Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study by Tartour, E, Blay, J Y, Dorval, T, Escudier, B, Mosseri, V, Douillard, J Y, Deneux, L, Gorin, I, Negrier, S, Mathiot, C, Pouillart, P, Fridman, W H

“…Various parameters have been reported to be correlated with response to interleukin-2 (IL-2) therapy. A multiinstitutional study was performed to assess by…”
Get more information

Breast tumour response to primary chemotherapy predicts local and distant control as well as survival by Scholl, S.M., Pierga, J.Y., Asselain, B., Beuzeboc, P., Dorval, T., Garcia-Giralt, E., Jouve, M., Palangié, T., Remvikos, Y., Durand, J.C., Fourquet, A., Pouillart, P.

“…The purpose of the present paper was to evaluate correlations between clinical response to chemotherapy and outcome in a subgroup analysis of premenopausal…”
Get full text

Spatially adaptive relaxation for active contour cell segmentation by Ogier, A, Dorval, T, Kim, B, Genovesio, A

“…This paper presents a segmentation framework in a high content screening (HCS) context based on variational snakes. We introduce a modified internal energy…”
Get full text

Prognostic factors for malignant uveal melanoma. Retrospective study on 2,241 patients and recent contribution of monosomy-3 research by Desjardins, L, Levy-Gabriel, C, Lumbroso-Lerouic, L, Sastre, X, Dendale, R, Couturier, J, Piperno-Neumann, S, Dorval, T, Mariani, P, Salmon, R, Plancher, C, Asselain, B

“…We conducted a retrospective study on the clinical factors influencing the local and general prognosis of patients treated for uveal melanoma with a…”
Get more information

99 Concurrent whole brain radiotherapy (WBRT) and trastuzumab (T) in breast cancer (BC) patients presenting with brain metastases by Riahi, H, Pierga, J.Y, Bollet, M.A, Cottu, P, Campana, F, Dendale, R, Dorval, T, Dieras, V, Fourquet, A, Kirova, Y.M

Get full text

Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients by Pierga, J. Y., Robain, M., Jouve, M., Asselain, B., Diéras, V., Beuzeboc, P., Palangié, T., Dorval, T., Extra, J.-M., Scholl, S., Pouillart, P.

“…Background: In cancer patients, correlation between response to chemotherapy and gain in survival remains debated. We addressed this question in a multivariate…”
Get full text

Cytokines and soluble cytokine receptor induction after IL‐12 administration in cancer patients by Haicheur, N., Escudier, B., Dorval, T., Negrier, S., De Mulder, P. H. M., Dupuy, J. M., Novick, D., Guillot, T., Wolf, S., Pouillart, P., Fridman, W. H., Tartour, E.

“…This study shows that subcutaneous administration of increasing doses of IL‐12, once a week, in 21 cancer patients increased the expression of cytokine genes…”
Get full text

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients by TARTOUR, E, DORVAL, T, MOSSERI, V, DENEUX, L, MATHIOT, C, BRAILLY, H, MONTERO, F, JOYEUX, I, POUILLART, P, FRIDMAN, W. H

“…Interleukin 6 and C-reactive protein (CRP) were determined prior to IL-2 therapy in sera from metastatic melanoma patients. Patients with elevated serum IL-6…”
Get full text

Treatment of liver metastases from uveal melanoma by combined surgery—chemotherapy by Salmon, R.J., Levy, C., Plancher, C., Dorval, T., Desjardins, L., Leyvrazi, S., Pouillart, P., Schlienger, P., Servois, V, Asselain, B.

“…To investigate sporadic results demonstrating prolonged survival after surgical resection and/or intraarterial chemotherapy (IACH) for liver metastases from…”
Get full text

Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer by Spielmann, M, Dorval, T, Turpin, F, Antoine, E, Jouve, M, Maylevin, F, Lacombe, D, Rouesse, J, Pouillart, P, Tursz, T

“…The study investigated the therapeutic effects of a combination of Navelbine (vinorelbine or 5'noranhydrovinblastine; Pierre Fabre Médicament, Boulogne,…”
Get more information